- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02549859
Long-term Effect of Low Frequency Stimulation on Aspiration and Freezing of Gait in PD With STN DBS
Long-term Effect of Low Frequency 60Hz Stimulation on Aspiration, Freezing of Gait and Other Axial and Motor Symptoms in PD Patients With Bilateral STN DBS
Study Overview
Status
Conditions
Detailed Description
The investigators will enroll 14 Parkinson patients with bilateral STN DBS and refractory FOG to 130Hz stimulation and dopaminergic medications for two visits of at least 6-month apart. The 6 patients remaining on 60Hz stimulation after our previous study consisting of 7 patients will be assessed once again as visit-2 after previous visit-1 of their last study. We anticipate to have 20 patents complete for visit-1 and at least 18 patients complete for visit-2 in this randomized double-blind prospective crossover study with their usual medication "on" state, with 6-7 patients on each starting condition (60Hz vs 130Hz vs DBS off). Swallowing function on modified barium swallowing test and swallowing questionnaire, FOG in stand-walk-sit test and questionnaire, and other axial and motor function on UPDRS-III will be assessed under each DBS condition. Changes in measurements between 60Hz and 130Hz at each visit and under 60Hz between two visits will be analyzed, with swallowing function and FOG as primary, and the rest as secondary outcomes, correcting for potential carryover effect. Changes between other DBS conditions might also be explored in this 2-year study.
This would be the first study on the long-term effect of 60Hz stimulation on dysphagia, FOG and other axial and motor symptoms in Parkinson patients with bilateral STN DBS and FOG refractory to 130Hz stimulation and dopaminergic medications, which will have significant impact on the treatment of difficult axial symptoms of high morbidity and mortality.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60637
- University of Chicago, Department of Neurology
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- PD patients with bilateral STN DBS placement and FOG at 130Hz even at usual medication "on" state.
Exclusion Criteria:
- Known history of recent aspiration pneumonia
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Deep Brain Stimulation (DBS)
All patients were treated and assessed under three conditions (60 Hz DBS, 130 Hz DBS and no DBS) at Visit 1 (V1), were then treated with 60 Hz DBS for at least 6 months (14.5 months on average), and were finally reassessed during a second visit (V2) under the same three conditions as V1.
The order of treatment/assessment under the three conditions was randomized at each visit.
|
Bilateral subthalamic nucleus deep brain stimulation at 60 Hz
Other Names:
Bilateral subthalamic nucleus deep brain stimulation at 130 Hz
Other Names:
Deep Brain Stimulation (DBS) Off (Sham)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Frequency of Aspiration Events on Videofluoroscopic Swallow Study at Visit 1
Time Frame: Immediately following treatment for at least 30 minutes
|
A speech pathologist used the Penetration-Aspiration Scale (PAS) to rate swallows captured by a radiologist during VFSS recording.
PAS is an 8-point interval scale: a score of 0 indicates no penetration or aspiration & a score of 6-8 indicates aspiration of increasing severity.
For the purpose of this study, aspiration was dichotomized to "0" if PAS score was under 6 or "1" if PAS score was between 6-8.
Frequency of aspiration events was calculated by adding number of aspiration events in VFSS under various liquid & food textures.
The maximum aspiration frequency was 12 if aspiration occurred on every texture after 2 trials.
Lower aspiration frequency means better swallowing function.
|
Immediately following treatment for at least 30 minutes
|
Perceived Swallowing Difficulty on Swallowing Disturbance Questionnaire at Visit 1
Time Frame: Immediately following treatment for at least 30 minutes
|
The Swallowing Disturbance Questionnaire contains 15 items.
Each item has 4-points ranging from 0 (absence of symptoms) to 3 (severe or very frequent).
Total score ranges from 0-45, with higher scores corresponding to more severe swallowing disturbance.
|
Immediately following treatment for at least 30 minutes
|
Freezing of Gait Questionnaire at Visit 1
Time Frame: Immediately following treatment for at least 30 minutes
|
The Freezing of Gait (FOG) Questionnaire contains 6 items to evaluate the severity of FOG in patients with Parkinson's disease.
Each item has 5 points ranging from 0 (absence of symptoms) to 4 (severe).
Total score ranges from 0-24, with higher scores corresponding to more severe FOG.
|
Immediately following treatment for at least 30 minutes
|
Stand-Walk-Sit Freezing of Gait Spells at Visit 1
Time Frame: Immediately following treatment for at least 30 minutes
|
The Stand-Walk-Sit (SWS) Test assesses freezing of gait (FOG) spells observed when standing up, walking 7 meters, and returning to a seated position.
The greater the number of FOG spells counted, the worse the FOG symptoms.
|
Immediately following treatment for at least 30 minutes
|
Stand-Walk-Sit Time at Visit 1
Time Frame: Immediately following treatment for at least 30 minutes
|
Stand-Walk-Sit (SWS) Time measures the total time taken to complete the SWS test of standing up, walking 7 meters, and returning to a sitting position.
The longer time (in seconds) it took to complete the SWS test, the worse the FOG symptoms.
|
Immediately following treatment for at least 30 minutes
|
Frequency of Aspiration Events on Videofluoroscopic Swallow Study at Visit 2
Time Frame: Immediately following treatment for at least 30 minutes
|
A speech pathologist used the Penetration-Aspiration Scale (PAS) to rate swallows captured by a radiologist during VFSS recording.
PAS is an 8-point interval scale: a score of 0 indicates no penetration or aspiration & a score of 6-8 indicates aspiration of increasing severity.
For the purpose of this study, aspiration was dichotomized to "0" if PAS score was under 6 or "1" if PAS score was between 6-8.
Frequency of aspiration events was calculated by adding number of aspiration events in VFSS under various liquid & food textures.
The maximum aspiration frequency was 12 if aspiration occurred on every texture after 2 trials.
Lower aspiration frequency means better swallowing function.
|
Immediately following treatment for at least 30 minutes
|
Perceived Swallowing Difficulty on Swallowing Disturbance Questionnaire at Visit 2
Time Frame: Immediately following treatment for at least 30 minutes
|
The Swallowing Disturbance Questionnaire contains 15 items.
Each item has 4-points ranging from 0 (absence of symptoms) to 3 (severe or very frequent).
Total score ranges from 0-45, with higher scores corresponding to more severe swallowing disturbance.
|
Immediately following treatment for at least 30 minutes
|
Freezing of Gait Questionnaire at Visit 2
Time Frame: Immediately following treatment for at least 30 minutes
|
The Freezing of Gait (FOG) Questionnaire contains 6 items to evaluate the severity of FOG in patients with Parkinson's disease.
Each item has 5 points ranging from 0 (absence of symptoms) to 4 (severe).
Total score ranges from 0-24, with higher scores corresponding to more severe FOG.
|
Immediately following treatment for at least 30 minutes
|
Stand-Walk-Sit Freezing of Gait Spells at Visit 2
Time Frame: Immediately following treatment for at least 30 minutes
|
The Stand-Walk-Sit (SWS) Test assesses freezing of gait (FOG) spells observed when standing up, walking 7 meters, and returning to a seated position.
The greater the number of FOG spells counted, the worse the FOG symptoms.
|
Immediately following treatment for at least 30 minutes
|
Stand-Walk-Sit Time at Visit 2
Time Frame: Immediately following treatment for at least 30 minutes
|
Stand-Walk-Sit (SWS) Time measures the total time taken to complete the SWS test of standing up, walking 7 meters, and returning to a sitting position.
The longer time (in seconds) it took to complete the SWS test, the worse the FOG symptoms.
|
Immediately following treatment for at least 30 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Unified Parkinson's Disease Rating Scale-III Total Score at Visit 1
Time Frame: Immediately following treatment for at least 30 minutes
|
Unified Parkinson's Disease Rating Scale-III (UPDRS-III) contains 33 items.
Each item has 5-points ranging from 0 (absence of symptoms) to 4 (severe).
Total score ranges from 0-132, with higher scores corresponding to more severe parkinsonism.
|
Immediately following treatment for at least 30 minutes
|
Axial Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 1
Time Frame: Immediately following treatment for at least 30 minutes
|
The axial subscore of Unified Parkinson's Disease Rating Scale-III (UPDRS-III) contains 7 items.
Each item has 5-points ranging from 0 (absence of symptoms) to 4 (severe).
Total score ranges from 0-28, with higher scores corresponding to more severe axial symptoms.
Specifically, axial symptoms include: speech, facial expression, arising from chair, gait, freezing of gait, postural stability, posture.
|
Immediately following treatment for at least 30 minutes
|
Bradykinesia Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 1
Time Frame: Immediately following treatment for at least 30 minutes
|
The bradykinesia subscore of Unified Parkinson's Disease Rating Scale-III (UPDRS-III) contains 11 items.
Each item has 5-points ranging from 0 (absence of symptoms) to 4 (severe).
Total score ranges from 0-44, with higher scores corresponding to more severe bradykinesia.
Specifically, bradykinesia symptoms include: finger tapping right hand, finger tapping left hand, hand movements right hand, hand movements left hand, pronation-supination movements right hand, pronation- supination movements left hand, toe tapping right foot, toe tapping left foot, leg agility right leg, leg agility left leg, global spontaneity of movement.
|
Immediately following treatment for at least 30 minutes
|
Rigidity Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 1
Time Frame: Immediately following treatment for at least 30 minutes
|
The rigidity subscore of Unified Parkinson's Disease Rating Scale-III (UPDRS-III) contains 5 items.
Each item has 5-points ranging from 0 (absence of symptoms) to 4 (severe).
Total score ranges from 0-20. with higher scores corresponding to more severe rigidity.
Specifically, rigidity symptoms include: rigidity neck, rigidity right upper extremity, rigidity left upper extremity, rigidity right lower extremity, rigidity left lower extremity.
|
Immediately following treatment for at least 30 minutes
|
Tremor Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 1
Time Frame: Immediately following treatment for at least 30 minutes
|
The tremor subscore of Unified Parkinson's Disease Rating Scale (UPDRS-III) contains 10 items.
Each item has 5-points ranging from 0 (absence of symptoms) to 4 (severe).
Total score ranges from 0-40, with higher scores corresponding to more severe tremor.
Specifically, tremor symptoms include: postural tremor right hand, postural tremor left hand, kinetic tremor right hand, kinetic tremor left hand, rest tremor amplitude right upper extremity, rest tremor amplitude left upper extremity, rest tremor amplitude right lower extremity, rest tremor amplitude left lower extremity, rest tremor amplitude lip/jaw, constancy of rest tremor.
|
Immediately following treatment for at least 30 minutes
|
Unified Parkinson's Disease Rating Scale-III Total Score at Visit 2
Time Frame: Immediately following treatment for at least 30 minutes
|
Unified Parkinson's Disease Rating Scale-III (UPDRS-III) contains 33 items.
Each item has 5-points ranging from 0 (absence of symptoms) to 4 (severe).
Total score ranges from 0-132, with higher scores corresponding to more severe parkinsonism.
|
Immediately following treatment for at least 30 minutes
|
Axial Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 2
Time Frame: Immediately following treatment for at least 30 minutes
|
The axial subscore of Unified Parkinson's Disease Rating Scale-III (UPDRS-III) contains 7 items.
Each item has 5-points ranging from 0 (absence of symptoms) to 4 (severe).
Total score ranges from 0-28, with higher scores corresponding to more severe axial symptoms.
Specifically, axial symptoms include: speech, facial expression, arising from chair, gait, freezing of gait, postural stability, posture.
|
Immediately following treatment for at least 30 minutes
|
Bradykinesia Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 2
Time Frame: Immediately following treatment for at least 30 minutes
|
The bradykinesia subscore of Unified Parkinson's Disease Rating Scale-III (UPDRS-III) contains 11 items.
Each item has 5-points ranging from 0 (absence of symptoms) to 4 (severe).
Total score ranges from 0-44, with higher scores corresponding to more severe bradykinesia.
Specifically, bradykinesia symptoms include: finger tapping right hand, finger tapping left hand, hand movements right hand, hand movements left hand, pronation-supination movements right hand, pronation- supination movements left hand, toe tapping right foot, toe tapping left foot, leg agility right leg, leg agility left leg, global spontaneity of movement.
|
Immediately following treatment for at least 30 minutes
|
Rigidity Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 2
Time Frame: Immediately following treatment for at least 30 minutes
|
The rigidity subscore of Unified Parkinson's Disease Rating Scale-III (UPDRS-III) contains 5 items.
Each item has 5-points ranging from 0 (absence of symptoms) to 4 (severe).
Total score ranges from 0-20. with higher scores corresponding to more severe rigidity.
Specifically, rigidity symptoms include: rigidity neck, rigidity right upper extremity, rigidity left upper extremity, rigidity right lower extremity, rigidity left lower extremity.
|
Immediately following treatment for at least 30 minutes
|
Tremor Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 2
Time Frame: Immediately following treatment for at least 30 minutes
|
The tremor subscore of Unified Parkinson's Disease Rating Scale (UPDRS-III) contains 10 items.
Each item has 5-points ranging from 0 (absence of symptoms) to 4 (severe).
Total score ranges from 0-40, with higher scores corresponding to more severe tremor.
Specifically, tremor symptoms include: postural tremor right hand, postural tremor left hand, kinetic tremor right hand, kinetic tremor left hand, rest tremor amplitude right upper extremity, rest tremor amplitude left upper extremity, rest tremor amplitude right lower extremity, rest tremor amplitude left lower extremity, rest tremor amplitude lip/jaw, constancy of rest tremor.
|
Immediately following treatment for at least 30 minutes
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Tao Xie, MD PhD, Department of Neurology, University of Chicago
Publications and helpful links
General Publications
- Xie T, Vigil J, MacCracken E, Gasparaitis A, Young J, Kang W, Bernard J, Warnke P, Kang UJ. Low-frequency stimulation of STN-DBS reduces aspiration and freezing of gait in patients with PD. Neurology. 2015 Jan 27;84(4):415-20. doi: 10.1212/WNL.0000000000001184. Epub 2014 Dec 24.
- Xie T, Bloom L, Padmanaban M, Bertacchi B, Kang W, MacCracken E, Dachman A, Vigil J, Satzer D, Zadikoff C, Markopoulou K, Warnke P, Kang UJ. Long-term effect of low frequency stimulation of STN on dysphagia, freezing of gait and other motor symptoms in PD. J Neurol Neurosurg Psychiatry. 2018 Sep;89(9):989-994. doi: 10.1136/jnnp-2018-318060. Epub 2018 Apr 13.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB 15-0539
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson's Disease
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
Assistance Publique - Hôpitaux de ParisFrance Parkinson AssociationUnknownHealthy Controls | Parkinson's Disease With LRRK2 Mutation | Parkinson's Disease Without LRRK2 MutationFrance
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
Universidade Federal de PernambucoCompletedParkinson's Disease.Brazil
-
University Hospital, GrenobleCompletedParkinson's Disease (Disorder)France
-
Neurocrine BiosciencesVoyager TherapeuticsCompletedBrain Diseases | Central Nervous System Diseases | Nervous System Diseases | Parkinson's Disease | Parkinsonian Disorders | Movement Disorders | Neurodegenerative Diseases | Idiopathic Parkinson's Disease | Basal Ganglia DiseaseUnited States
-
Second Affiliated Hospital of Soochow UniversityShanghai Regenelead Therapies Co., Ltd.RecruitingAdvanced Parkinson's DiseaseChina
-
AbbVieRecruitingParkinson's Disease (PD)Germany, Denmark, Spain
-
Beijing Tiantan HospitalRecruitingPD - Parkinson's DiseaseChina
-
Hubert FernandezRecruitingParkinson's Disease, IdiopathicUnited States
Clinical Trials on Deep Brain Stimulation (DBS) at 60 Hz
-
The University of Western AustraliaCompletedParkinson's Disease | TremorAustralia
-
Ruijin HospitalActive, not recruitingMajor Depressive Disorder | Deep Brain StimulationChina
-
Beijing Pins Medical Co., LtdPeking Union Medical College HospitalCompleted
-
Boston Scientific CorporationCompletedParkinson's DiseaseUnited States
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Paul LarsonCompleted
-
Stanford UniversityCompletedParkinson's DiseaseUnited States
-
University Hospital, MontpellierCompletedObsessive-compulsive Disorder (OCD)France
-
Ali Rezai, MDCompleted
-
A.O. Ospedale Papa Giovanni XXIIIAssociazione Italiana Parkinsoniani (AIP)- Sezione BergamoUnknownParkinson's Disease | Deep Brain Stimulation | DBS | STNItaly